Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study.
Clin Gastroenterol Hepatol
; 19(12): 2675-2676.e2, 2021 12.
Article
en En
| MEDLINE
| ID: mdl-33161161
ABSTRACT
Obesity is closely associated with nonalcoholic fatty liver disease. A minority of patients with nonalcoholic fatty liver disease progress to liver cirrhosis and end-stage liver disease.1 Weight loss results in improvement of liver histology in persons with nonalcoholic fatty liver disease.2 Because weight loss can be challenging to achieve and sustain in persons with obesity, bariatric surgery is considered a feasible therapeutic option for persons with severe obesity.3 Bariatric surgery leads to improved glucose tolerance, weight loss, and improved overall mortality.4 It is less well known if bariatric surgery also reduces the incidence of liver-related outcomes. Here, we analyzed liver-related outcomes in the Swedish Obese Subjects (SOS) cohort.5.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Cirugía Bariátrica
/
Enfermedad del Hígado Graso no Alcohólico
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
País como asunto:
Europa
Idioma:
En
Año:
2021
Tipo del documento:
Article